Bill Status of HB4362  101.th General Assembly

Short Description:  IMPORTED PRESCRIPTION DRUGS

House Sponsors
Rep. Anna Moeller - Natalie A. Manley - Gregory Harris, Sam Yingling, Terra Costa Howard and Mary Edly-Allen

Last Action
DateChamber Action
  1/13/2021HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act


Synopsis As Introduced
Creates the Wholesale Importation of Prescription Drugs Act. Requires the Department of Public Health to design an importation program where the State is the licensed wholesaler of imported drugs from licensed, regulated Canadian suppliers. Requires the program to address specified issues, including billing issues, cost savings issues, and safety and regulatory issues. Contains auditing and reporting requirements. Provides that the Department shall enlist the assistance of the Attorney General to identify the potential for anti-competitive behavior in industries that would be affected by an importation program. Requires the Department to submit a formal request to the Secretary of the United States Department of Health and Human Services for certification of the importation program. Requires the Department to have the program operational within 6 months after receiving the certification. Contains provisions concerning implementation requirements.

Actions 
DateChamber Action
  1/29/2020HouseFiled with the Clerk by Rep. Anna Moeller
  1/29/2020HouseFirst Reading
  1/29/2020HouseReferred to Rules Committee
  2/4/2020HouseAdded Chief Co-Sponsor Rep. Natalie A. Manley
  3/4/2020HouseAdded Chief Co-Sponsor Rep. Gregory Harris
  3/12/2020HouseAssigned to Prescription Drug Affordability & Accessibility Committee
  3/12/2020HouseAdded Co-Sponsor Rep. Sam Yingling
  6/23/2020HouseRule 19(b) / Re-referred to Rules Committee
  6/25/2020HouseAdded Co-Sponsor Rep. Terra Costa Howard
  6/25/2020HouseAdded Co-Sponsor Rep. Mary Edly-Allen
  1/13/2021HouseSession Sine Die